Company intelligence / Profile preview

Ju Dong Yang

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Judongyang is a South Korean biotechnology company focused on the development of pharmaceutical products and functional health supplements derived from natural sources. The company specializes in identifying bioactive compounds from traditional medicinal plants to address chronic conditions such as inflammation and metabolic disorders. Judongyang integrates traditional knowledge with modern pharmacological screening to develop its pipeline of therapeutic candidates. Its business model encompasses both the research and development of new drug candidates and the commercialization of health-promoting functional foods.

Therapeutic areas: ImmunologyMetabolic Disorders
Modalities: Small moleculeNatural products
Industry: Biotech

Beyond the preview

Go deeper on Ju Dong Yang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ju Dong Yang.

Explore the full profile